4Filing Date: Aug 31, 2026
Edwards Lifesciences (EW)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-007408
Total Value$49.5K
Trades1
Insiders1
Transaction Details
Dahl Andrew M.
SVP, Corporate Controller·Direct
Sell · Dispose
Common Stock
Shares-544
Price$91.06
Total Value$49.5K
Shares Owned After14.87K
Transaction DateAug 31, 2026
Post-Transaction Holdings
Dahl Andrew M. · SVP, Corporate Controller
| Security | Shares | Change |
|---|---|---|
| Common Stock | 14.87K | -544 (-3.53%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-31
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Dahl Andrew M.
CIK: 0002022347
Role: Officer (SVP, Corporate Controller)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-08-31 | Code: S (Open market sale)
Shares: -544 | Price: $91.06
Total Value: $49,533.92
Shares Owned After: 14,868.41 | Ownership: D (Direct)
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-08-31)